Multiple Manufacturers

HUMIRA

Manufacturer:

Multiple Manufacturers

Humira HCPCS:

J0135

HCPCS Code Descriptor:

Injection, adalimumab, 20 mg

Category:

J Code

Humira NDCs:

00074-0124-04, 00074-0124-03, 00074-2540-03, 00074-4339-06, 00074-0124-02, 00074-4339-07, 00074-1539-03, 00074-0067-02, 00074-0243-02, 00074-0817-02, 00074-0616-02, 00074-0554-02, 00074-3799-02, 00074-4339-02

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Multi-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00074-4339-07

About Humira:

HUMIRA is an Immunology:Anti-TNF drug manufactured by Abbvie and administered via the Subcutaneous route of administration. The J Code: J0135 is aligned to the drug HUMIRA.

ACCESS PRICING AND MORE BY REGISTERING

J0135 Added Date:

January 1, 2005

J0135 Effective Date:

January 1, 2005

J0135 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Humira billing and coding information.
Humira patient assistance information can be found through the myAbbVie Assist Program at the URL: https://www.abbvie.com/patients/patient-assistance/program-qualification/humira-program-selection.html
HUMIRA prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for HUMIRA. Please check back in a few weeks.